DE69128273T2 - Für toxin b von clostridium difficile spezifische monoklonale antikörper - Google Patents

Für toxin b von clostridium difficile spezifische monoklonale antikörper

Info

Publication number
DE69128273T2
DE69128273T2 DE69128273T DE69128273T DE69128273T2 DE 69128273 T2 DE69128273 T2 DE 69128273T2 DE 69128273 T DE69128273 T DE 69128273T DE 69128273 T DE69128273 T DE 69128273T DE 69128273 T2 DE69128273 T2 DE 69128273T2
Authority
DE
Germany
Prior art keywords
toxin
monoclonal antibodies
clostridium difficile
specific monoclonal
difficile specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69128273T
Other languages
English (en)
Other versions
DE69128273D1 (de
Inventor
Richard Coughlin
Dante Marciani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meridian Bioscience Inc
Original Assignee
Meridian Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meridian Diagnostics Inc filed Critical Meridian Diagnostics Inc
Publication of DE69128273D1 publication Critical patent/DE69128273D1/de
Application granted granted Critical
Publication of DE69128273T2 publication Critical patent/DE69128273T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69128273T 1990-05-11 1991-05-06 Für toxin b von clostridium difficile spezifische monoklonale antikörper Expired - Fee Related DE69128273T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/522,881 US5231003A (en) 1990-05-11 1990-05-11 Monoclonal antibodies specific for toxin b of clostridium difficile
PCT/US1991/003108 WO1991018293A1 (en) 1990-05-11 1991-05-06 Monoclonal antibodies specific for toxin b of clostridium difficile

Publications (2)

Publication Number Publication Date
DE69128273D1 DE69128273D1 (de) 1998-01-08
DE69128273T2 true DE69128273T2 (de) 1998-06-25

Family

ID=24082747

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69128273T Expired - Fee Related DE69128273T2 (de) 1990-05-11 1991-05-06 Für toxin b von clostridium difficile spezifische monoklonale antikörper

Country Status (11)

Country Link
US (1) US5231003A (de)
EP (1) EP0482176B1 (de)
JP (1) JPH05500011A (de)
AT (1) ATE160575T1 (de)
AU (1) AU655586B2 (de)
CA (1) CA2063709A1 (de)
DE (1) DE69128273T2 (de)
DK (1) DK0482176T3 (de)
ES (1) ES2110993T3 (de)
IE (1) IE911617A1 (de)
WO (1) WO1991018293A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610023A (en) * 1995-03-31 1997-03-11 Lee Laboratories, Inc. Method of purification of clostridium difficile toxin A and production of mono-specific antibodies
US7179611B2 (en) * 1997-02-10 2007-02-20 Bd Lee Laboratories Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A
US5965375A (en) * 1997-04-04 1999-10-12 Biosite Diagnostics Diagnostic tests and kits for Clostridium difficile
DE19739685A1 (de) * 1997-09-10 1999-03-11 Eichel Streiber Christoph Von Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
US6290946B1 (en) 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
MXPA05000687A (es) * 2002-07-22 2005-04-08 Genzyme Corp Poli (estirenosulfonato potasico y sodico), su fabricacion y sus usos.
AU2005320349C1 (en) * 2004-02-06 2019-06-13 E. R. Squibb & Sons, L.L.C. Antibodies against clostridium difficile toxins and uses thereof
WO2006044577A1 (en) * 2004-10-13 2006-04-27 Ilypsa, Inc. Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle
US20060078534A1 (en) * 2004-10-13 2006-04-13 Dominique Charmot Toxin binding compositions
US8598321B2 (en) 2007-03-22 2013-12-03 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
WO2009108652A1 (en) 2008-02-28 2009-09-03 3M Innovative Properties Company Antibodies to clostridium difficile spores and uses thereof
WO2010014854A2 (en) 2008-07-31 2010-02-04 The Regents Of The University Of California Antibodies that neutralize botulinum neurotoxins
ES2589606T3 (es) * 2009-07-27 2016-11-15 Biodics Gmbh Procedimiento para la detección y para la identificación de una cepa de C. difficile variante en una muestra
ES2757675T3 (es) * 2010-04-15 2020-04-29 Progenics Pharm Inc Anticuerpos para el tratamiento de la infección y enfermedad asociada a Clostridium difficile
WO2012047427A2 (en) 2010-08-31 2012-04-12 The Regents Of The University Of California Antibodies for botulinum neurotoxins
EP4365196A2 (de) 2011-04-22 2024-05-08 Wyeth LLC Zusammensetzungen im zusammenhang mit einem mutierten clostridium-difficile-toxin und verfahren dafür
SG10201804809RA (en) 2011-08-22 2018-07-30 Cnj Holdings Inc Clostridium difficile antibodies
US8790880B2 (en) * 2011-09-26 2014-07-29 Techlab, Inc. Cysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficile
CN108101983A (zh) 2012-03-02 2018-06-01 瑞泽恩制药公司 艰难梭状芽孢杆菌毒素的人源抗体
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
CN112812189B (zh) * 2020-11-30 2022-05-17 四川大学华西医院 一种抗糖基转移酶a亚单位的纳米抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533630A (en) * 1982-09-13 1985-08-06 Wilkins Tracy D Toxins and antibodies of C. difficile
US4879218A (en) * 1982-09-13 1989-11-07 Virginia Tech Intellectual Properties, Inc. Antibody for C.difficile
EP0154064A1 (de) * 1984-03-02 1985-09-11 Tracy Dale Wilkins Toxine und Antikörper von C. Difficile

Also Published As

Publication number Publication date
JPH05500011A (ja) 1993-01-14
ES2110993T3 (es) 1998-03-01
EP0482176A1 (de) 1992-04-29
US5231003A (en) 1993-07-27
DE69128273D1 (de) 1998-01-08
CA2063709A1 (en) 1991-11-12
IE911617A1 (en) 1991-11-20
DK0482176T3 (da) 1998-05-18
ATE160575T1 (de) 1997-12-15
WO1991018293A1 (en) 1991-11-28
EP0482176A4 (en) 1992-08-05
AU7883091A (en) 1991-12-10
EP0482176B1 (de) 1997-11-26
AU655586B2 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
ATE177754T1 (de) Fragmente von prion proteinen.
DE68914244T2 (de) Monoklonaler Antikörper.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ES2188927T3 (es) Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo.
NO843293L (no) Monoklonale antistoffer, samt fremgangsmaate for fremstilling av slike
ES551495A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos o merozoitos de eimeria spp.
GR3031607T3 (en) Selective system scan for multizone radiotelephone subscriber units.
DK407987A (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
NO843591L (no) Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DE3886545T2 (de) Monoklonale human-antikörper, spezifisch für rh(d).
DK0556320T3 (da) Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
DK329789D0 (da) Monoklonalt antistof
DK0677117T3 (da) Sondring mellem HTLV-I og HTLV-II under anvendelse af syntetiske peptider
NO890116L (no) Monoklonale antistoffer.
FI974018A (fi) Ihmisen 2 integriini -alayksikkö
NO861554L (no) Anti-urokinasemonoklonalt antistoff, matrise inneholdende dette, testmetode og biokjemisk testutstyr som anvender det.
DE69023717T2 (de) Monoklonaler Antikörper.
NO894555L (no) Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet.
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee